David Silberman

Mr. Silberman serves as Chief Financial Officer of Oramed Pharmaceuticals. He joined Oramed in 2021. From 2018 until 2021, Mr. Silberman served as a Corporate Financial Planning and Analysis Director at Teva Pharmaceutical Industries Ltd., a global pharmaceutical company. From 2014 to 2018, Mr. Silberman served as Global Internal Audit Senior Manager at Teva Pharmaceutical Industries Ltd. From 2009 to 2014, Mr. Silberman provided internal audit and risk management services in the advisory department of Grant Thornton Fahn Kanne Control Management. Prior to that, Mr. Silberman worked in the audit department of KPMG, a certified public accounting firm.

Mr. Silberman holds a DCG and a DSCG degree from the French Ministry of Higher Education and Research and is a certified public accountant in Israel.